Skip to main content
Premium Trial:

Request an Annual Quote

France Funds $17M Cancer Profiling, Biomarker Effort

NEW YORK (GenomeWeb News) – The French government has provided €13.4 million ($17.4 million) to fund the Innovative MODels Initiative (IMODI), a partnership aimed at facilitating the development of new cancer treatments.

Headed by Oncodesign, a preclinical cancer therapy assessment firm, the IMODI partners plan to pool their resources to develop, profile, and evaluate more than 200 experimental cancer models, tests for molecular selection, and a range of derivative biological products.

They also will create a centralized biobank that will include over 40,000 samples and data analysis tools for identifying tumor and immunological biomarkers, as well as biomarkers from the microbiome.

The funding was awarded by the French government agency OSEO, which supports research projects and technology transfer, guarantees funding from banks and equity capital investors, and funds investments along with banks.

The overall budget for the seven-year IMODI project is expected to be €41 million.

Oncodesign's partners in the project include commercial partners Sanofi; Servier; Ipsen; Pierre Fabre; Transgene; Biofortis; Oncomedics; Ariana Pharma; and CTI Biotech.

IMODI also will include partners at seven French institutions, including the French National Institute of Health and Medical Research; the National Center for Scientific Research; the Georges Francois Leclerc Center in Dijon; the Leon Berard Center in Lyon; Synergie Lyon Cancer; the University of Strasboug; and Toulouse University Hospital.

"This project offers a unique opportunity to increase the rate of innovation and identification of cancer therapies and biomarkers, with the creation of an organized national structure designed for the development of personalized medicine which directly benefits patients," Oncodesign President and CEO Philippe Genne said in a statement.

The Scan

International Team Proposes Checklist for Returning Genomic Research Results

Researchers in the European Journal of Human Genetics present a checklist to guide the return of genomic research results to study participants.

Study Presents New Insights Into How Cancer Cells Overcome Telomere Shortening

Researchers report in Nucleic Acids Research that ATRX-deficient cancer cells have increased activity of the alternative lengthening of telomeres pathway.

Researchers Link Telomere Length With Alzheimer's Disease

Within UK Biobank participants, longer leukocyte telomere length is associated with a reduced risk of dementia, according to a new study in PLOS One.

Nucleotide Base Detected on Near-Earth Asteroid

Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.